FDA issues marketing approval for Imvexxy
https://www.chaindrugreview.com/wp/app/uploads/2018/05/IMVEXXY_MNR_ABOUT_IMVEXXY.mp4 
https://www.chaindrugreview.com/wp/app/uploads/2018/05/IMVEXXY_MNR_ABOUT_IMVEXXY.mp4 BOCA RATON, Fla. — TherapeuticsMD, an innovative women’s healthcare company, announced that the United States Food and Drug Administration (FDA) has approved Imvexxy (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia (vaginal pain associated with sexual activity), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Imvexxy is the only product in
